Financial insights of PCRX

MyFinsight

For the quarter ending 2025-09-30, PCRX made $179,516K in revenue. $5,432K in net income. Net profit margin of 3.03%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenues	179,516	181,099	168,923	168,573
Cost of goods sold	34,278	40,866	34,306	38,864
Research and development	25,966	28,200	25,342	19,104
Selling, general and administrative	91,797	88,578	86,776	74,333
Contingent consideration (gains) charges, restructuring charges and other	-	-	-	1,766
Amortization of acquired intangible assets	14,322	14,322	14,322	14,322
Goodwill impairment	0	-	-	163,243
Contingent consideration charges (gains), acquisition-related expenses, restructuring and other	6,791	634	6,187	-
Total operating expenses	173,154	172,600	166,933	308,100
Income (loss) from operations	6,362	8,499	1,990	-139,527
Interest income	8,534	5,008	6,895	5,482
Interest expense	4,279	4,695	4,580	4,689
(loss) gain on early extinguishment of debt	-983	0	-	-
Other, net	-110	-10,739	4,401	-122
Total other income (expense), net	3,162	-10,426	6,716	671
Income (loss) before income taxes	9,524	-1,927	8,706	-138,856
Income tax expense	4,092	2,920	3,894	4,610
Net income (loss)	5,432	-4,847	4,812	-143,466

Basic (in shares)	44,038,000	45,459,000	46,275,000	46,134,000
Basic net income (loss) per common share (in dollars per share)	0.12	-0.11	0.1	-3.11
Diluted (in shares)	44,459,000	45,459,000	46,526,000	46,134,000
Diluted net income (loss) per common share (in dollars per share)	0.12	-0.11	0.1	-3.11